Is Cortical Motor Neuron Dysfunction the Underlying Mechanism of Fatigue in Fibromyalgia?

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to test whether cortical motor neuron dysfunction plays a role in the pathogenesis of fatigue in fibromyalgia patients. The main questions it aims to answer are: Do fibromyalgia patients have lower v-wave compared to healthy subjects? Does cheering affect V-wave in fibromyalgia patients more than healthy subjects? Researchers will compare the V-waves of fibromyalgia patients with those of healthy subjects.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:

• Diagnosed with fibromyalgia according to acr 2016 criteria(for fibromyalgia group)

• Being healthy(for control group)

• 18-60 years old

• Volunteering

• Being female

• Right hand dominant

Locations
Other Locations
Turkey
Istanbul Physical Medicine Rehabilitation Training & Research Hospital
RECRUITING
Istanbul
Contact Information
Primary
Fuat O. Alayoğlu, M.D.
f.orhunalayoglu@gmail.com
5348431984
Backup
İlhan Karacan, Prof. Dr.
mdkaracanilhan@gmail.com
5327005361
Time Frame
Start Date: 2024-04-18
Estimated Completion Date: 2025-05
Participants
Target number of participants: 36
Treatments
Experimental: Fibromyalgia
Subjects with diagnosed fibromyalgia will be in this arm. Subjects will have their grip strength and 4-meter walking speed measured and will be asked to fill the fatigue severity scale.~Subjects will be tested for v-wave during voluntary foot plantarflexion.
Experimental: Healthy
Healthy subjects will be in this arm. Subjects will have their grip strength and 4-meter walking speed measured and will be asked to score the fatigue severity scale.~Subjects will be tested for v-wave during voluntary foot plantarflexion.
Related Therapeutic Areas
Sponsors
Leads: Istanbul Physical Medicine Rehabilitation Training and Research Hospital

This content was sourced from clinicaltrials.gov